A Historical Perspective of Healthcare Disparity and Infectious Disease in the Native American PopulationArticle Published on 2022-01-242023-06-23 Journal: The American journal of the medical sciences [Category] COVID19(2023년), SARS, 신종인플루엔자, [키워드] alcoholism coronavirus COVID-19 Epidemic Epidemiology hantavirus healthcare disparities hepatitis A HIV medical history Native American Pandemic, Small pox poverty Sanitation SARS-CoV-2 Tuberculosis [DOI] 10.1016/j.amjms.2022.01.005 PMC 바로가기
Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control studyCOVID-19로 입원한 환자의 임상 악화 위험 요소: 사례 대조 연구Article Published on 2022-01-012022-09-11 Journal: Revista clínica española [Category] SARS, 치료기술, [키워드] 95%CI Acute myocardial infarction age Analysis ARDS arterial AUC baseline Care case-control study chest X-ray clinical Clinical deterioration Clinical practice Cohort collected Comorbidities Control COPD COVID-19 CRP date of onset Deterioration Deterioro clínico dry cough emergency department English Factor Factores pronósticos Factors female high risk ICU admission identify independent variable independent variables Logistic regression Logistic regression analysis medical history Multivariate analysis Myocardial infarction outcomes pacientes hospitalizado Patient patients hospitalized PCR Platelet Platelets predictor Prognostic factors radiological risk factor Risk factors saturation service severe ARDS Sex sociodemographic data sore throat Spanish thrombocytopenia Univariate analysis variable [DOI] 10.1016/j.rceng.2021.04.009 PMC 바로가기 [Article Type] Article
Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 20212020 년 9 월부터 2021 년 2 월까지 미국에서 Covid-19를 가진 입원 환자의 실제 치료 패턴 및 임상 결과Research Article Published on 2021-12-282022-09-10 Journal: PLoS ONE [Category] SARS, 치료제, [키워드] adults hospitalized age alleviate Care Characteristics Clinical improvement Clinical outcome clinical outcomes Cohort cohorts COVID-19 database demographics Dexamethasone diabete diabetes diagnosed with COVID-19 died discharge discharged effective Electronic health record Electronic health records Evidence evidence of Follow-up Health health resource highlight hospital Hospitalized hypertension ICU care identify index initiated Inpatient invasive ventilation majority medical history medical procedures morbidity and mortality most prevalent comorbidities most prevalent comorbidity Non-invasive obesity outcome oxygen oxygen supplementation Patient patient age patient disposition patients patients hospitalized prevalent remained Remdesivir required resource retrospective cohort study Standard deviation stratified subsequent the United State Treatment treatments for COVID-19 United States unmet need was used with COVID-19 [DOI] 10.1371/journal.pone.0261707 PMC 바로가기 [Article Type] Research Article
Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes인간 눈의 사후 샘플에서 SARS-CoV-2-RNA 검출Miscellaneous Published on 2021-12-282022-09-11 Journal: Graefe's Archive for Clinical and Experimental Oph [Category] COVID19(2023년), MERS, SARS, 변종, 치료기술, [키워드] all subject all subjects Alpha analyzed association biopsy circulating Comorbidities Comorbidity concerning Conjunctiva conjunctival Conjunctival swab conjunctivitis Corneal transplantation correlated correlation correlations COVID-19 COVID-19 patients Deceased detect detection determine diagnosis of COVID-19 distribution evaluated examination eye eyes Frequency Genome sequencing in some Infection Intraocular involvement intravitreal Lineage load medical history Munich occur Ocular symptom ocular symptoms ophthalmologic surgical procedures Patient patients with COVID-19 performed Planning Post-mortem Prospective respiratory Result SARS-CoV-2 SARS-CoV-2 detection SARS-CoV-2 PCR SARS-CoV-2 RNA Sequencing spreading surgery Surgical Procedure Symptoms syndrome tear film tissue variant variants Viral Viral load vitreous Vitreous sample VoC were recorded whole genome Whole genome sequencing [DOI] 10.1007/s00417-021-05529-x PMC 바로가기 [Article Type] Miscellaneous
SARS-CoV-2 viral load assessment in lung transplantation폐 이식에서 SARS-CoV-2 바이러스 부하 평가Case Reports Published on 2021-12-162022-09-11 Journal: Physiological research [Category] SARS, 치료법, [키워드] Antigen Bronchoalveolar lavage complex COVID-19 COVID-19 pandemic criteria Ct value Ct values cycle threshold decision Diagnosis Donor IgA antibodies IgA antibody Laboratory lung lung transplantation medical history Nasopharyngeal swab organ Organ donor organ transplantation PCR proceed Respiratory disease SARS-CoV-2 nucleocapsid SARS-CoV-2 viral load serum solid organ Support thought transplantation viability Viral load Viral RNA [DOI] 10.33549/physiolres.934760 PMC 바로가기 [Article Type] Case Reports
Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care dataResearch Article Published on 2021-12-092022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] 95%CI age age and sex all-cause mortality approach association average Cancer cause-specific mortality co-morbidity comparable components COVID-19 COVID-19 pandemic database death Dementia Deprivation EMR England Factor First wave increase in Interaction London medical history mental illness methodology Mortality objective pandemic Patient Poisson regression primary care produced Result retrospective cohort study risk factor Sex significantly smoking Total total mortality vital status [DOI] 10.1371/journal.pone.0260381 PMC 바로가기 [Article Type] Research Article
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital프랑스 대학 병원의 경증 내지 중증 COVID-19 환자를 위한 임상 실습에서 하이드록시클로로퀸의 자비로운 사용Observational Study Published on 2021-12-062022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 신약개발, 임상, [키워드] addition Admission age Analysis analyzed Arterial hypertension Charlson Comorbidity Index clinical Comorbidity conducted confidence interval confounder confounders contraindication contraindications Controlled trial coronavirus disease Coronavirus disease 2019 COVID-19 death decision defined determine dosage effective French group hazard ratio help Hospitalized Hydroxychloroquine hypertension initial intensive care intensive care unit laboratory-confirmed Laboratory-confirmed COVID-19 medical history Mild National Early Warning Score NEWS2 Nonrandomized studies nonrandomized study not significantly different obesity outcome overall survival Patient patients treated Pneumonia Practice primary analysis primary endpoint Propensity score reduced risk reduction retrospective cohort study risk SARS-CoV-2 score severe COVID-19 severity Sex significantly Standard of care suggested symptom onset the mean the median therapeutic therapeutic agent Treatment treatment of COVID-19 university university hospital was performed Weighting with COVID-19 [DOI] 10.1093/cid/ciaa791 PMC 바로가기 [Article Type] Observational Study
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study미국과 페루에서 SARS-CoV-2 감염에서 회복된 인구통계학적 및 임상적으로 다양한 개인에서 시간이 지남에 따라 항체 반응 중화: 코호트 연구Research Article Published on 2021-12-062022-09-12 Journal: PLoS Medicine [Category] 진단, [키워드] 293T/ACE2 cells acute respiratory syndrome coronavirus age age and sex analyses Analysis antibody Antibody Response applied assigned association Asymptomatic Birth Blood body mass body mass index Clinical characteristics clinical manifestations Clinical outcome clinical outcomes clinically Cohort cohort study collected Comorbidities Comorbidity convalescent convalescent individual convalescent individuals coronavirus 2 coronavirus disease Coronavirus disease 2019 correlation COVID-19 death declined demographic and clinical characteristics Demographic variables demographics diabete diabetes disease onset disease severity enrolled Factors help heterogeneity highlighting Hispanic hypertension identify immune defense immune response immune responses Immunity implementation in some include individual Infection limitation Linear regression Male sex medical history mild illness Multiple Multiple linear regression NAb NAb responses NAb titers NAbs nasal samples natural history Neutralizing antibodies neutralizing antibody Neutralizing antibody response neutralizing antibody responses not differ observation participant peaked Protective pulmonary disease Questionnaires researcher respiratory response responses SARS-CoV-2 SARS-CoV-2 antibody response SARS-COV-2 infection SARS-CoV-2 spike protein serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe coronavirus disease Sex smoking Spike protein survivorship the United State therapeutic strategy Therapeutics thought titers to define Treatment Trial registration United States Vaccine Variation variety Viral load virus virus infection were measured white [DOI] 10.1371/journal.pmed.1003868 PMC 바로가기 [Article Type] Research Article
COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American MalesCovid-19는 아프리카 계 미국인 남성의 병원 결과를 예측할 수있는 염증 및 신장 마커를 조절합니다.Article Published on 2021-12-022022-08-31 Journal: Viruses [Category] SARS, 바이오마커, [키워드] addition Admission African American African Americans age Care CCL2 CCL3 clinical factors collected control group controls COVID-19 COVID-19 patient COVID-19 patients cytokine Cytokines death demographics eight electronic medical records elevated evaluated Evidence Factor GST Hospital mortality Hospitalization Hospitalized ICU ICU patient ICU Patients IL-18 IL-33 IL-6 immune response immune responses In-hospital in-hospital mortality Infection Inflammatory response initial Injury interleukin male males marker MCP-1 MCP-1/CCL2 medical history medical records MIP-1α MIP-1α/CCL3 non-ICU non-ICU patients osteopontin outcome patients patients hospitalized plasma samples Population populations Prognostic factor Prognostic factors renal renal toxicity reported Retrospective study risk SARS-CoV-2 selected Seven single-center suffered Toxicity upregulated variables [DOI] 10.3390/v13122415 PMC 바로가기 [Article Type] Article
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialCovid-19 (회복)로 병원에 입원 한 환자의 콜히친 : 무작위, 통제, 오픈 라벨, 플랫폼 시험Randomized Controlled Trial Published on 2021-12-012022-08-13 Journal: The Lancet. Respiratory Medicine [Category] MERS, SARS, 임상, [키워드] (Medical Research Council) 1:1 28-day mortality allocation concealment Analysis anti-inflammatory actions assigned baseline both groups by mouth clinically suspected clinician Colchicine colchicine 1 mg colchicine group composite endpoint CYP3A4 CYP3A4 inhibitor death died Diltiazem discharge discharged Efficacy and safety eligible enrolled estimated glomerular filtration rate evaluate filtration rate finding followed by for inclusion Frequency funding glomerular filtration rate had no hospital Hospital stay hospitalised hospitals in Indonesia hospitals in Nepal in both groups Indonesia Innovation Intention intention-to-treat Invasive mechanical ventilation ISRCTN Laboratory less medical history Medical Research Council moderate nasogastric tube Nepal no significant difference Open-label open-label trial opinion participant Patient Platform trial Primary outcome proportion randomisation randomised Randomly rate ratio receive receiving RECOVERY trial reductions reductions in Registered risk risk ratio SARS-COV-2 infection secondary endpoint Secondary endpoints significant difference Standard of care subgroups of patients the patient Treatment treatment for COVID-19 Trial twice a day usual care usual care group web-based simple Wellcome Trust with COVID-19 [DOI] 10.1016/S2213-2600(21)00435-5 PMC 바로가기 [Article Type] Randomized Controlled Trial